Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Finegold, SM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wexler, HM; Molitoris, E; Molitoris, D; Finegold, SM
      In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria

      Journal of antimicrobial chemotherapy
    2. Wexler, HM; Molitoris, E; Molitoris, D; Finegold, SM
      In vitro activity of moxifloxacin against 179 strains of anaerobic bacteria found in pulmonary infections

      ANAEROBE
    3. Talan, DA; Summanen, PH; Finegold, SM
      Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and othersoft-tissue abscesses in patients with or without histories of injection drug abuse

      CLINICAL INFECTIOUS DISEASES
    4. Sandler, RH; Finegold, SM; Bolte, ER; Buchanan, CP; Maxwell, AP; Vaisanen, ML; Nelson, MN; Wexler, HM
      Short-term benefit from oral vancomycin treatment of regressive-onset autism

      JOURNAL OF CHILD NEUROLOGY
    5. Wexler, HM; Molitoris, D; Finegold, SM
      In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobicbacteria

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    6. Claros, MC; Schumacher, U; Jacob, M; Gerardo, SH; Kleinkauf, N; Goldstein, EJC; Finegold, SM; Rodloff, AC
      Characterization of Bilophila wadsworthia isolates using PCR fingerprinting

      ANAEROBE
    7. Wexler, HM; Molitoris, E; Molitoris, D; Finegold, SM
      In vitro activity of HMR 3004 (RU 64004) against 502 strains of anaerobic bacteria

      ANAEROBE
    8. Summanen, PH; McTeague, M; Vaisanen, ML; Strong, CA; Finegold, SM
      Comparison of recovery of anaerobic bacteria using the Anoxomat (R), anaerobic chamber, and GasPak (R) jar systems

      ANAEROBE
    9. Finegold, SM
      Swan song

      CLINICAL INFECTIOUS DISEASES
    10. Finegold, SM
      Recollections of an early anaerobist

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    11. Finegold, SM
      In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    12. Matto, J; Asikainen, S; Vaisanen, ML; von Troil-Linden, B; Kononen, E; Saarela, M; Salminen, K; Finegold, SM; Jousimies-Somer, H
      beta-lactamase production in Prevotella intermedia, Prevotella nigrescens,and Prevotella pallens genotypes and in vitro susceptibilities to selectedantimicrobial agents

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    13. Allo, MD; Bennion, RS; Kathir, K; Thompson, JE; Lentz, M; Meute, M; Finegold, SM
      Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis

      AMERICAN SURGEON
    14. FINEGOLD SM
      UNTITLED

      Anaerobe (Print)
    15. GERARDO SH; GARCIA MM; WEXLER HM; FINEGOLD SM
      ADHERENCE OF BILOPHILA-WADSWORTHIA TO CULTURED HUMAN EMBRYONIC INTESTINAL-CELLS

      Anaerobe
    16. Wexler, HM; Finegold, SM
      Current susceptibility patterns of anaerobic bacteria

      YONSEI MEDICAL JOURNAL
    17. MOSCA A; SUMMANEN P; FINEGOLD SM; DEMICHELE G; MIRAGLIOTTA G
      CELLULAR FATTY-ACID COMPOSITION, SOLUBLE-PROTEIN PROFILE, AND ANTIMICROBIAL RESISTANCE PATTERN OF EUBACTERIUM-LENTUM

      Journal of clinical microbiology
    18. WEXLER HM; MOLITORIS E; MOLITORIS D; FINEGOLD SM
      IN-VITRO ACTIVITY OF LEVOFLOXACIN AGAINST A SELECTED GROUP OF ANAEROBIC-BACTERIA ISOLATED FROM SKIN AND SOFT-TISSUE INFECTIONS

      Antimicrobial agents and chemotherapy
    19. KONONEN E; MATTO J; VAISANENTUNKELROTT ML; FRANDSEN EVG; HELANDER I; ASIKAINEN S; FINEGOLD SM; JOUSIMIESSOMER H
      BIOCHEMICAL AND GENETIC-CHARACTERIZATION OF A PREVOTELLA INTERMEDIA NIGRESCENS-LIKE ORGANISM/

      International journal of systematic bacteriology
    20. FINEGOLD SM; GOLDSTEIN EJC
      PROCEEDINGS OF THE 1996 MEETING OF THE ANAEROBE-SOCIETY-OF-THE-AMERICA - CHICAGO, ILLINOIS - 19-21 JULY 1996 - INTRODUCTION

      Clinical infectious diseases
    21. FINEGOLD SM; JOUSIMIESSOMER H
      RECENTLY DESCRIBED CLINICALLY IMPORTANT ANAEROBIC-BACTERIA - MEDICAL ASPECTS

      Clinical infectious diseases
    22. RAUTIO M; LONNROTH M; SAXEN H; NIKKU R; VAISANEN ML; FINEGOLD SM; JOUSIMIESSOMER H
      CHARACTERISTICS OF AN UNUSUAL ANAEROBIC PIGMENTED GRAM-NEGATIVE ROD ISOLATED FROM NORMAL AND INFLAMED APPENDIXES

      Clinical infectious diseases
    23. VAISANEN ML; KIVIRANTA M; SUMMANEN P; FINEGOLD SM; JOUSIMIESSOMER HR
      PORPHYROMONAS ENDODONTALIS-LIKE ORGANISMS FROM EXTRAORAL SOURCES

      Clinical infectious diseases
    24. FINEGOLD SM
      PERSPECTIVE ON SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA

      Clinical infectious diseases
    25. MOLITORIS E; WEXLER HM; FINEGOLD SM
      SOURCES AND ANTIMICROBIAL SUSCEPTIBILITIES OF CAMPYLOBACTER-GRACILIS AND SUTTERELLA-WADSWORTHENSIS

      Clinical infectious diseases
    26. FINEGOLD SM
      INTRODUCTION

      Clinical infectious diseases
    27. KONONEN E; VAISANEN ML; FINEGOLD SM; HEINE R; JOUSIMIESSOMER H
      CELLULAR FATTY-ACID ANALYSIS AND ENZYME PROFILES OF PORPHYROMONAS-CATONIAE - A FREQUENT COLONIZER OF THE ORAL CAVITY IN CHILDREN

      Anaerobe
    28. TUNER K; WEXLER HM; REEVES D; FINEGOLD SM
      PENICILLIN-BINDING PROTEINS IN FUSOBACTERIUM SPECIES

      Anaerobe
    29. FINEGOLD SM; WEXLER HM
      PRESENT STATUS OF THERAPY FOR ANAEROBIC INFECTIONS

      Clinical infectious diseases
    30. SNYDMAN DR; MCDERMOTT L; CUCHURAL GJ; HECHT DW; IANNINI PB; HARRELL LJ; JENKINS SG; OKEEFE JP; PIERSON CL; RIHS JD; YU VL; FINEGOLD SM; GORBACH SL
      ANALYSIS OF TRENDS IN ANTIMICROBIAL RESISTANCE PATTERNS AMONG CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS GROUP SPECIES FROM 1990 TO 1994

      Clinical infectious diseases
    31. WEXLER HM; MOLITORIS E; MURRAY PR; WASHINGTON J; ZABRANSKY RJ; EDELSTEIN PH; FINEGOLD SM
      COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION (VOL 34, PG 174, 1996)

      Journal of clinical microbiology
    32. WEXLER HM; MOLITORIS E; MURRAY PR; WASHINGTON J; ZABRANSKY RJ; EDELSTEIN PH; FINEGOLD SM
      COMPARISON OF SPIRAL GRADIENT END-POINT AND AGAR DILUTION METHODS FORSUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA - A MULTILABORATORY COLLABORATIVE EVALUATION

      Journal of clinical microbiology
    33. WEXLER HM; MOLITORIS E; MOLITORIS D; FINEGOLD SM
      IN-VITRO ACTIVITIES OF TROVAFLOXACIN AGAINST 557 STRAINS OF ANAEROBIC-BACTERIA

      Antimicrobial agents and chemotherapy
    34. OBRIEN WA; HARTIGAN PM; MARTIN D; ESINHART J; HILL A; BENOIT S; RUBIN M; LAHART C; WRAY N; FINEGOLD SM; GEORGE WL; DICKINSON GM; KLIMAS N; DIAMOND G; ZOLLAPAZNER SB; JENSEN PC; HAWKES C; OSTER C; GORDIN F; LABRIOLA AM; SPIVEY P; MATTHEWS T; WEINHOLD K; DRUSANO G; EGORIN MJ
      CHANGES IN PLASMA HIV-1 RNA AND CD4+ LYMPHOCYTE COUNTS AND THE RISK OF PROGRESSION TO AIDS

      The New England journal of medicine
    35. WEXLER HM; REEVES D; SUMMANEN PH; MOLITORIS E; MCTEAGUE M; DUNCAN J; WILSON KH; FINEGOLD SM
      SUTTERELLA WADSWORTHENSIS GEN-NOV, SP-NOV, BILE-RESISTANT MICROAEROPHILIC CAMPYLOBACTER GRACILIS-LIKE CLINICAL ISOLATES

      International journal of systematic bacteriology
    36. BARTON LL; FINEGOLD SM
      UNTITLED

      Anaerobe
    37. FINEGOLD SM
      ANAEROBIC-SOCIETY-OF-THE-AMERICA

      Anaerobe
    38. FINEGOLD SM
      ANAEROBIC INFECTIONS IN HUMANS - AN OVERVIEW

      Anaerobe
    39. MOSCA A; DALAGNI M; DELPRETE R; DEMICHELE GP; SUMMANEN PH; FINEGOLD SM; MIRAGLIOTTA G
      PRELIMINARY EVIDENCE OF ENDOTOXIC ACTIVITY OF BILOPHILA-WADSWORTHIA

      Anaerobe
    40. FINEGOLD SM
      ASPIRATION PNEUMONIA

      Seminars in respiratory and critical care medicine
    41. GOLDSTEIN EJC; SUMMANEN PH; CITRON DM; ROSOVE MH; FINEGOLD SM
      FATAL SEPSIS DUE TO A BETA-LACTAMASE-PRODUCING STRAIN OF FUSOBACTERIUM-NUCLEATUM SUBSPECIES POLYMORPHUM

      Clinical infectious diseases
    42. SOMER T; FINEGOLD SM
      VASCULITIDES ASSOCIATED WITH INFECTIONS, IMMUNIZATION, AND ANTIMICROBIAL DRUGS

      Clinical infectious diseases
    43. SEBALD M; FINEGOLD SM
      PASTEUR - THE ANAEROBIC LIFE AND THE ANAEROBES

      Clinical infectious diseases
    44. MOLITORIS D; SUMMANEN P; FINEGOLD SM; HERMAN J; WEXLER HM
      DIFFERENTIATION OF BACTEROIDES-GRACILIS, BACTEROIDES-GRACILIS-LIKE ORGANISMS, AND CAMPYLOBACTER SPECIES ON THE BASIS OF DEHYDROGENASE PATTERNS

      Clinical infectious diseases
    45. MULLIGAN ME; KWOK RYY; MOLITORIS D; SUMMANEN P; WEXLER H; FINEGOLD SM
      IMMUNOBLOT TYPING OF BACTEROIDES GRACILIS

      Clinical infectious diseases
    46. BARON EJ; STRONG CA; MCTEAGUE M; VAISANEN ML; FINEGOLD SM
      SURVIVAL OF ANAEROBES IN ORIGINAL SPECIMENS TRANSPORTED BY OVERNIGHT MAIL SERVICES

      Clinical infectious diseases
    47. DURMAZ B; JOUSIMIESSOMER HR; FINEGOLD SM
      ENZYMATIC PROFILES OF PREVOTELLA, PORPHYROMONAS, AND BACTEROIDES SPECIES OBTAINED WITH THE API ZYM SYSTEM AND ROSCO DIAGNOSTIC TABLETS

      Clinical infectious diseases
    48. FINEGOLD SM
      OVERVIEW OF CLINICALLY IMPORTANT ANAEROBES

      Clinical infectious diseases
    49. JOUSIMIESSOMER HR; SUMMANEN P; FINEGOLD SM
      BACTEROIDES LEVII-LIKE ORGANISMS ISOLATED FROM CLINICAL SPECIMENS

      Clinical infectious diseases
    50. SUMMANEN PH; JOUSIMIESSOMER H; MANLEY S; BRUCKNER D; MARINA M; GOLDSTEIN EJC; FINEGOLD SM
      BILOPHILA-WADSWORTHIA ISOLATES FROM CLINICAL SPECIMENS

      Clinical infectious diseases
    51. CIVEN R; JOUSIMIESSOMER H; MARINA M; BORENSTEIN L; SHAH H; FINEGOLD SM
      A RETROSPECTIVE REVIEW OF CASES OF ANAEROBIC EMPYEMA AND UPDATE OF BACTERIOLOGY

      Clinical infectious diseases
    52. SUMMANEN PH; TALAN DA; STRONG C; MCTEAGUE M; BENNION R; THOMPSON JE; VAISANEN ML; MORAN G; WINER M; FINEGOLD SM
      BACTERIOLOGY OF SKIN AND SOFT-TISSUE INFECTIONS - COMPARISON OF INFECTIONS IN INTRAVENOUS-DRUG-USERS AND INDIVIDUALS WITH NO HISTORY OF INTRAVENOUS DRUG-USE

      Clinical infectious diseases
    53. FINEGOLD SM; HORWITZ MA; JOHNSON BL
      HEWITT,WILLIAM,LANE - IN-MEMORIAM

      Clinical infectious diseases
    54. FINEGOLD SM
      CENTENNIAL SYMPOSIUM ON ANAEROBES - A MEMORIAL TO VEILLON,ANDRE - THESECRET PATHOGENS - INTRODUCTION

      Clinical infectious diseases
    55. FINEGOLD SM
      REVIEW OF EARLY RESEARCH ON ANAEROBES

      Clinical infectious diseases
    56. SNYDMAN DR; CUCHURAL GJ; MCDERMOTT L; IANNINI PB; HARRELL LJ; CLEARY TJ; OKEEFE JP; HECHT D; PIERSON CL; RIHS JD; FINEGOLD SM; ZEVROS; GORBACH; FRY; BROOK
      SUSCEPTIBILITY VARIATIONS IN BACTEROIDES-FRAGILIS - A NATIONAL SURVEY

      Infectious diseases in clinical practice
    57. WEXLER HM; MOLITORIS E; FINEGOLD SM
      IN-VITRO ACTIVITY OF GREPAFLOXACIN (OPC-17116) AGAINST ANAEROBIC-BACTERIA

      Diagnostic microbiology and infectious disease
    58. NITZAN Y; WEXLER HM; FINEGOLD SM
      INACTIVATION OF ANAEROBIC-BACTERIA BY VARIOUS PHOTOSENSITIZED PORPHYRINS OR BY HEMIN

      Current microbiology
    59. WEXLER HM; MOLITORIS E; REEVES D; FINEGOLD SM
      IN-VITRO ACTIVITY OF CLINAFLOXACIN (CI-960) AND PD-131628-2 AGAINST ANAEROBIC-BACTERIA

      Journal of antimicrobial chemotherapy
    60. WEXLER HM; MOLITORIS E; FINEGOLD SM
      THE IN-VITRO ACTIVITY OF L-627 AGAINST ANAEROBIC-BACTERIA

      Journal of antimicrobial chemotherapy
    61. SAPICO FL; REEVES D; WEXLER HM; DUNCAN J; WILSON KH; FINEGOLD SM
      PRELIMINARY-STUDY USING SPECIES-SPECIFIC OLIGONUCLEOTIDE PROBE FOR RIBOSOMAL-RNA OF BILOPHILA-WADSWORTHIA

      Journal of clinical microbiology
    62. WEXLER HM; MOLITORIS E; REEVES D; FINEGOLD SM
      IN-VITRO ACTIVITY OF DU-6859A AGAINST ANAEROBIC-BACTERIA

      Antimicrobial agents and chemotherapy
    63. WEXLER HM; MOLITORIS E; FINEGOLD SM
      IN-VITRO ACTIVITIES OF 2 NEW GLYCYLCYCLINES, N,N-DIMETHYLGLYCYLAMIDO DERIVATIVES OF MINOCYCLINE AND 6-DEMETHYL-6-DEOXYTETRACYCLINE, AGAINST339 STRAINS OF ANAEROBIC-BACTERIA

      Antimicrobial agents and chemotherapy
    64. WARD TT; THOMAS RG; FYE CL; ARBEIT R; COLTMAN CA; CRAIG W; DANA BW; FINEGOLD SM; LENTINO J; PENN RL; WEINBERG JB; CHOW B; OCHI S; WEBER JH; LAYARD MW; CHANG P; GREENBERG P; RIMLAND D; BALDIWIN V; MIREAULT K; LAWRENCE W; STANKO S; HOBBS E; OLMSTEAD C; INGRAMDRAKE L; NEILL HB; DISNEY C; YU V; HAMILTON R; LYMAN GH; LYMAN C; GALGIANI J; KIZZIER F; AMON M; GRINICH K; SEWELL D; BASSETT R; JACOBSON I; JAMES KE; FETTER R; MONTANO L; HICKS R; SATHER MR; YOUNG LM; WEBER JH
      TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS IN GRANULOCYTOPENIC PATIENTS WITH ACUTE-LEUKEMIA - EVALUATION OF SERUM ANTIBIOTIC LEVELS IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY

      Clinical infectious diseases
    65. FINEGOLD SM
      SUMMARY OF CURRENT NOMENCLATURE, TAXONOMY, AND CLASSIFICATION OF VARIOUS MICROBIAL AGENTS

      Clinical infectious diseases
    66. FINEGOLD SM
      DUPLICATE SUBMISSION AND PUBLICATION OF CORRESPONDENCE - REPLY

      Clinical infectious diseases
    67. FINEGOLD SM; GOLDSTEIN EJC
      PROCEEDINGS OF THE 1ST NORTH-AMERICAN CONGRESS ON ANAEROBIC-BACTERIA AND ANAEROBIC INFECTIONS MARINA-DEL-REY, CALIFORNIA 24-26 JULY 1992

      Clinical infectious diseases
    68. STRONG CA; MCTEAGUE M; VAISANEN ML; HERMAN J; FINEGOLD SM
      CHARACTERIZATION OF AN UNUSUAL MICROAEROPHILIC ORGANISM CLOSELY RELATED TO BACTEROIDES-GRACILIS

      Clinical infectious diseases
    69. MARINA M; STRONG CA; CIVEN R; MOLITORIS E; FINEGOLD SM
      BACTERIOLOGY OF ANAEROBIC PLEUROPULMONARY INFECTIONS - PRELIMINARY-REPORT

      Clinical infectious diseases
    70. CIVEN R; VAISANEN ML; FINEGOLD SM
      PERITONSILLAR ABSCESS, RETROPHARYNGEAL ABSCESS, MEDIASTINITIS, AND NONCLOSTRIDIAL ANAEROBIC MYONECROSIS - A CASE-REPORT

      Clinical infectious diseases
    71. BARON EJ; VAISANEN ML; MCTEAGUE M; STRONG CA; NORMAN D; FINEGOLD SM
      COMPARISON OF THE ACCU-CULSHURE SYSTEM AND A SWAB PLACED IN A B-D PORT-A-CUL TUBE FOR SPECIMEN COLLECTION AND TRANSPORT

      Clinical infectious diseases
    72. FINEGOLD SM
      A CENTURY OF ANAEROBES - A LOOK BACKWARD AND A CALL TO ARMS

      Clinical infectious diseases
    73. FINEGOLD SM; STRONG CA; MCTEAGUE M; MARINA M
      THE IMPORTANCE OF BLACK-PIGMENTED GRAM-NEGATIVE ANAEROBES IN HUMAN INFECTIONS

      FEMS immunology and medical microbiology
    74. FINEGOLD SM
      HOST FACTORS PREDISPOSING TO ANAEROBIC INFECTIONS

      FEMS immunology and medical microbiology
    75. FINEGOLD SM; JOUSIMIESSOMER HR; WEXLER HM
      CURRENT PERSPECTIVES ON ANAEROBIC INFECTIONS - DIAGNOSTIC APPROACHES

      Infectious disease clinics of North America
    76. SUMMANEN P; WEXLER HM; LEE K; BECKER SAWE; GARCIA MM; FINEGOLD SM
      MORPHOLOGICAL RESPONSE OF BILOPHILA-WADSWORTHIA TO IMIPENEM - CORRELATION WITH PROPERTIES OF PENICILLIN-BINDING PROTEINS

      Antimicrobial agents and chemotherapy
    77. WEXLER HM; MOLITORIS E; FINEGOLD SM
      IN-VITRO ACTIVITY OF BAY Y3118 AGAINST ANAEROBIC-BACTERIA

      Antimicrobial agents and chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 13:55:38